Literature DB >> 14698536

Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC).

Canten Tataroğlu1, Aydanur Kargi, Sermin Ozkal, Nalan Eşrefoğlu, Atilla Akkoçlu.   

Abstract

The association between inflammatory cells, including tumor associated macrophage (TAM), mast cell (MC) and eosinophil leucocyte (EL) densities and angiogenesis, as well as the relation of TAM, MC and EL densities and angiogenesis to tumor stage were investigated in specimens of 63 non-small cell lung carcinoma (NSCLC). Fifteen cases were in stage I, 12 were in stage II, 33 were in stage III and 3 were in stage IV. ELs and MCs were identified by hematoxilen-eosin and toluidine-blue histochemical stains, respectively. TAMs were shown by immunohistochemistry for CD68. Microvessels demonstrated by immunohistochemistry for CD31 were quantified by a stereological method and vascular surface density (VSD) and microvessel number (NVES) were calculated. There was not any statistically significant correlation between tumor's stage and VSD, TAM and EL counts. MC count and NVES were found to be higher in early stages. VSD and NVES were not associated with EL, MC and TAM counts. The lack of consistent correlation of angiogenesis to the stage of disease in this study supports the view that tumor angiogenesis is not a significant prognostic factor in NSCLCs. The absence of correlation between MCs, ELs and TAM counts and angiogenesis and absence of any relation between ELs and TAMs and tumor stage are discordant with the results of some of the previous studies in NSCLCs and in other tumors. The differing results may be due to wide variations in methodologies which were used for demonstration of inflammatory cells and vessels and variations in the degree of activation and complexity of functions of these cells.

Entities:  

Mesh:

Year:  2004        PMID: 14698536     DOI: 10.1016/j.lungcan.2003.08.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  15 in total

1.  Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLC.

Authors:  S A Almatroodi; C F McDonald; I A Darby; D S Pouniotis
Journal:  Cancer Microenviron       Date:  2015-08-30

Review 2.  Eosinophils: The unsung heroes in cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Valeria Lucarini; Giancarlo Marone; Fabrizio Mattei; Gianni Marone; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

Review 3.  Eosinophils and Lung Cancer: From Bench to Bedside.

Authors:  Anne Sibille; Jean-Louis Corhay; Renaud Louis; Vincent Ninane; Guy Jerusalem; Bernard Duysinx
Journal:  Int J Mol Sci       Date:  2022-05-03       Impact factor: 6.208

Review 4.  Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients.

Authors:  Denisa Baci; Elona Cekani; Andrea Imperatori; Domenico Ribatti; Lorenzo Mortara
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

5.  SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment.

Authors:  Bo Huang; Zhang Lei; Gui-Mei Zhang; Dong Li; Chuanwang Song; Bo Li; Yanyan Liu; Ye Yuan; Jay Unkeless; Huabao Xiong; Zuo-Hua Feng
Journal:  Blood       Date:  2008-06-04       Impact factor: 22.113

6.  Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer.

Authors:  Jon G Quatromoni; Evgeniy Eruslanov
Journal:  Am J Transl Res       Date:  2012-10-10       Impact factor: 4.060

7.  Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases.

Authors:  Ashish B Rajput; Dmitry A Turbin; Maggie Cu Cheang; David K Voduc; Sam Leung; Karen A Gelmon; C Blake Gilks; David G Huntsman
Journal:  Breast Cancer Res Treat       Date:  2007-03-13       Impact factor: 4.872

8.  Mast cells and eosinophils in invasive breast carcinoma.

Authors:  Rose-Marie Amini; Kirsimari Aaltonen; Heli Nevanlinna; Ricardo Carvalho; Laura Salonen; Päivi Heikkilä; Carl Blomqvist
Journal:  BMC Cancer       Date:  2007-08-29       Impact factor: 4.430

9.  Any defining role of mast cell or mast cell density in oral squamous cell carcinoma?

Authors:  O Ozdemir
Journal:  Ann Med Health Sci Res       Date:  2014-11

10.  Chronic Inflammation: Synergistic Interactions of Recruiting Macrophages (TAMs) and Eosinophils (Eos) with Host Mast Cells (MCs) and Tumorigenesis in CALTs. M-CSF, Suitable Biomarker for Cancer Diagnosis!

Authors:  Mahin Khatami
Journal:  Cancers (Basel)       Date:  2014-01-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.